Back
Moelis & Co. 10K Form
Sell
32
MC
Moelis & Co.
Last Price:
$65.97
Seasonality Move:
-10.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | MC/Moelis & Co. Quarterly |
| 2023-11-03 | 10Q | MC/Moelis & Co. Quarterly |
| 2023-07-27 | 10Q | MC/Moelis & Co. Quarterly |
| 2023-04-27 | 10Q | MC/Moelis & Co. Quarterly |
| 2022-11-03 | 10Q | MC/Moelis & Co. Quarterly |
| 2022-07-28 | 10Q | MC/Moelis & Co. Quarterly |
Receive MC News And Ratings
See the #1 stock for the next 7 days that we like better than MC
MC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5B |
|---|---|
| Cash Flow: | $179.6M |
| Price / Cash Flow: | 10.65 |
| Annual Sales: | $7.23 |
| Price / Book: | 9.12 |
Profitability
| EPS (TTM): | 2.93790 |
|---|---|
| Net Income (TTM): | $259.6M |
| Gross Margin: | $0 |
| Return on Equity: | 49.05% |
| Return on Assets: | 19.07% |
Moelis & Co. Earnings Forecast
Key Moelis & Co. Financial Ratios
-
The Gross Profit Margin over the past 15 years for MC is 0.00%.
-
The Selling, General & Administrative Expenses for MC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of MC is 17.12% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Moelis & Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Capital Markets |
| Sector: | Financials |
| Current Symbol: | MC |
| CUSIP: | 60786M |
| Website: | moelis.com |
Debt
| Debt-to-Equity Ratio: | 0.5 |
|---|---|
| Current Ratio: | 0.6 |
| Quick Ratio: | 0.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.43 |
|---|---|
| Forward P/E Ratio: | 15.49 |
MC Technical Analysis vs Fundamental Analysis
Sell
32
Moelis & Co. (MC)
is a Sell
Is Moelis & Co. a Buy or a Sell?
-
Moelis & Co. stock is rated a SellThe current Moelis & Co. [MC] share price is $65.94. The Score for MC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.